Rising scholars published in prestigious law journals - College of Law

Rising scholars published in prestigious law journals

From left: Anna Carpenter, Matt Lamkin and Stephen Galoob.

The University of Tulsa College of Law is a Top 100 law school that provides a dynamic doctrinal and experiential legal education. The faculty at TU not only impact students’ experiences through their classrooms and clinics, but also through publishing high-level scholarly articles, papers and opinions.

Most recently, TU faculty published or have articles forthcoming in prestigious law journals including Yale Law Journal, Stanford Law Review, Notre Dame Law Review, Arizona Law Review, BYU Law Review, University of Illinois Law Review, U.C. Davis Law Review, Constitutional Commentary, Hastings Law Journal and Lewis & Clark Law Review. TU Law’s prominent scholars include Anna Carpenter LL.M, J.D.; Stephen Galoob, Ph.D., J.D.; and Matt Lamkin, J.D.

“I am very proud that The University of Tulsa College of Law boasts such diverse and groundbreaking scholarly articles by its faculty,” said TU Law Dean Lyn Entzeroth. “Our professors provide deep and meaningful value to our law students and to the legal community.

Carpenter is an associate clinical professor of law and director of the Lobeck-Taylor Community Advocacy Clinic. Her scholarship includes empirical and theoretical work on access to justice and the role of lawyers, non-lawyers and judges in the civil justice system. Professor Anna Carpenter’s most recent article, “Active Judging and Access to Justice,” is forthcoming in the Notre Dame Law Review and another, “Measuring Clinics” is forthcoming in the Tulane Law Review (with Colleen F. Shanahan, Alyx Mark, and Jeff Selbin).

She also recently published “Trial and Error: Lawyers and Nonlawyer Advocates” in the peer-reviewed journal, Law and Social Inquiry; “Lawyers, Power, and Strategic Expertise” in the Denver Law Review; and “Can a Little Representation Be a Dangerous Thing?” in the Hastings Law Journal (all three with Colleen F. Shanahan and Alyx Mark).

Galoob is an associate professor of law whose scholarly work examines fundamental questions in criminal law, torts, contracts and professional responsibility. He is currently writing articles concerning blackmail, the nature of norms, fiduciary concepts, reparation and political legitimacy.

Galoob’s essay (with Ethan Leib), “Fiduciary Political Theory: A Critique,” was published in the Yale Law Journal in 2016. In 2017, Galoob published “Coercion, Fraud, and What Is Wrong With Blackmail” in Legal Theory; “Retributivism and Criminal Procedure” in New Criminal Law Review; “The Ethical Identity of Law Students” (with coauthors) in International Journal of the Legal Profession; and “Living Up To (and Under) Norms” in Tulsa Law Review.

Galoob’s forthcoming publications include “The Core of Fiduciary Political Theory” (with Ethan Leib) in Research Handbook on Fiduciary Law; “Fiduciary Principles and Public Offices” (with Ethan Leib) in Oxford Handbook of Fiduciary Law; “Fiduciary Political Theory and Legitimacy (with Ethan Leib) in Fiduciary Government; and “Climbing the Mountain of Criminal Procedure” in American Journal of Comparative Law.

Lamkin is an associate professor of law whose scholarship explores the intersection of health care, law and ethics with a focus on how the increasing commercialization of medical care is reshaping our understandings of disease and disability, informed consent and personal responsibility, and the role of government in regulating medical care.

Lamkin’s article, “Medical Regulation as Social Control,” was published in the BYU Law Review (2016). He has coauthored a series of articles with philosopher Carl Elliott at the University of Minnesota, including “Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation,” Journal of Law, Medicine, & Ethics (forthcoming 2018); “Involuntarily Committed Patients as Prisoners,” University of Richmond Law Review (2017); “Restrict the Recruitment of Involuntarily Committed Patients for Psychiatric Research,” JAMA Psychiatry (2016); and “Curing the Disobedient Patient: Medication Adherence Programs as Pharmaceutical Marketing Tools,” Journal of Law, Medicine, & Ethics (2014).